Anaplastic Oligodendroglioma

Showing 26 - 40 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gliomas, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Los Angeles (alloreactive CTL)

Completed
  • Gliomas
  • +5 more
  • alloreactive CTL
  • Los Angeles, California
    University of California, Los Angeles
May 26, 2016

Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma Trial in Seoul (Temozolomide)

Completed
  • Anaplastic Oligodendroglioma
  • Anaplastic Oligoastrocytoma
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 22, 2016

Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma Trial run by the NCI (ZD6474 (Vandetanib), Carboplatin)

Completed
  • Glioblastoma Multiforme
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 25, 2016

Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma Trial run by the NCI (biological, drug, procedure)

Completed
  • Glioblastoma
  • +4 more
  • Bevacizumab
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2015

Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Gliomas Trial (carmustine, mercaptopurine, streptozocin)

Completed
  • Anaplastic Astrocytoma
  • +4 more
  • (no location specified)
Mar 24, 2015

Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma Trial in Chicago (AXL1717)

Unknown status
  • Glioblastoma
  • +5 more
  • Chicago, Illinois
    Rush University Medical Center
Jan 8, 2015

Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma Trial in San Francisco (Nanoliposomal CPT-11)

Completed
  • Glioblastoma
  • +3 more
  • Nanoliposomal CPT-11
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2015

Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma Trial in Geneva (Sorafenib dose escalation)

Completed
  • Glioblastoma
  • +4 more
  • Sorafenib dose escalation
  • Geneva, GE, Switzerland
    Geneva University Hospital (Hopitaux Universitaires de Geneve),
Oct 31, 2014

Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma Trial in Boston, Cleveland, Charlottesville (BIBF 1120)

Completed
  • Glioblastoma
  • +4 more
  • BIBF 1120
  • Boston, Massachusetts
  • +3 more
Aug 15, 2014

Brain Tumor, Anaplastic Astrocytoma, Anaplastic Ependymoma Trial in Cleveland (ritonavir, lopinavir)

Terminated
  • Brain Tumor
  • +8 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Apr 24, 2013

Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma Trial in Durham (enzyme-inducing anti-epileptic drugs)

Withdrawn
  • Glioblastoma Multiforme
  • +4 more
  • enzyme-inducing anti-epileptic drugs
  • Durham, North Carolina
    Duke University Medical Center
Nov 20, 2012

Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma Trial in Beijing (Carmustine, tumor resection

Unknown status
  • Anaplastic Astrocytoma
  • +3 more
  • Beijing, Beijing, China
    Beijing Tiantan Hospital Affiliated to Capital Medical Universit
Aug 2, 2012

Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma Trial in Guangzhou (Carmustine(BCNU), Surgery)

Unknown status
  • Anaplastic Astrocytoma
  • +3 more
  • Guangzhou, Guangzhou, China
    Sun Yat-Sen University Cancer Center
Jul 8, 2012

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Durham (IL13-PE38QQR, targeted fusion protein

Completed
  • Malignant Glioma
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Jun 2, 2011

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (Talampanel)

Terminated
  • Glioblastoma Multiforme
  • +3 more
  • (no location specified)
May 20, 2011